Clinical Trials Directory

Trials / Completed

CompletedNCT02168959

Continuous Femoral Nerve Block With a Tibial Plateau Fracture

Postoperative Pain Management With a Continuous Femoral Nerve Block in Patients With a Tibial Plateau Fracture

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
5 (actual)
Sponsor
University of Utah · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary purpose of the proposed study is to compare postoperative pain scores and total opioid consumption between two groups randomized to either receive or not receive a femoral nerve block for pain control following surgical repair of a tibial plateau fracture. Pain will be assessed post-operatively using standard numeric pain scores rated on a 0 - 10 scale, as well as using the University new pain assessment tool - the Clinically Aligned Pain Assessment (CAPA). This new 5 question pain assessment tool has not yet been validated, but does address several key questions, including patient comfort, pain control, change in pain status, daily functioning, and sleep quality. Along with post-operative pain scores, we will compare total opioid consumption between the two groups. The null hypothesis is that there is no difference in pain scores or total opioid consumption between patients receiving a femoral nerve block and those without a nerve block following surgical repair of a tibial plateau fracture. A secondary outcome will examine long-term pain control, range of motion, and functional status of these patients at their regular orthopedic clinic follow-up appointments. The same pain scores will be assessed, along with quadriceps strength and knee range of motion. Patients will complete the PROMIS Physical Function CAT and short Musculoskeletal Function Assessment, patient reported outcomes tools to evalute physical function. A teriary outcome will be to retrospectively examine postoperative pain scores and total opioid consumption for all tibial plateau fracture patients seen at the University of Utah for surgical repair in the past 10 years.

Conditions

Interventions

TypeNameDescription
DRUGbupivacaineThis drug is standard of care. The point of the study is to see if this method will yield better pain scores and improved patient satisfaction vs. non-nerve block. Simply: prospective observation of two standard methods.

Timeline

Start date
2013-02-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2014-06-20
Last updated
2016-03-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02168959. Inclusion in this directory is not an endorsement.